The growth of malignant keratinocytes depends on signaling through the PGE2 receptor EP1

Neoplasia

Volumn 3, Issue 5, 2001, Pages 402-410

  Thompson, Eric J ^a   Gupta, Ashok ^c   Vielhauer, George A ^a   Regan, John W ^a   Bowden, G Tim ^a,b,d  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

COX 1; COX 2; EP1; Keratinocyte growth; PGE2; Tumor progression

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN EP1 RECEPTOR; PROSTAGLANDIN EP4 RECEPTOR; PROSTANOID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL GROWTH; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME INHIBITION; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET B RADIATION;

EID: 0034775863     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900182     Document Type: Article

References (59)

1. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
2. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
3. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
4. Aspirin and the potential role of prostaglandins in colon cancer
5. Prostaglandin endoperoxide H synthases-1 and -2
6. Prostaglandin E2 stimulates expression of matrix metalloproteinase 2 in cultured rat mesangial cells
7. Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor
8. Interleukin-4, transforming growth factor beta 1, and dexamethasone inhibit superantigen-induced prostaglandin E2-dependent collagenase gene expression through their action on cyclooxygenase-2 and cytosolic phospholipase A2
9. Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells
10. Vasoactive agents modulate matrix metalloproteinase-2 activity by mesangial cells
11. Roles of prostanoids revealed from studies using mice lacking specific prostanoid receptors
12. Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro
13. Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice
14. Crucial involvement of the EP4 subtype of prostaglandin E receptor in osteoclast formation by proinflammatory cytokines and lipopolysaccharide
15. Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype
16. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: An analysis using specific agonists for the respective EPs
17. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme
18. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase
19. COX-2 expression is induced by UVB exposure in human skin: Implications for the development of skin cancer
20. Molecular pathology of cyclooxygenase-2 in neoplasia
21. Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation
22. Host cyclooxygenase-2 modulates carcinoma growth
23. The induction of cyclooxygenase-1 by a tobacco carcinogen in U937 human macrophages is correlated to the activation of NF-kappaB
24. Prostaglandin E(2) regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors
25. Chemical and enzymic conversions of the prostaglandin endoperoxide PGH2
26. Enzymes involved in the formation and further transformations of prostaglandin endoperoxides
27. Purification of PGH-PGE isomerase from sheep vesicular glands
28. Changes in arachidonic acid metabolism in UV-irradiated hairless mouse skin
29. Ultraviolet-evoked prostaglandin biosynthesis in varying stages of keratinocyte differentiation in guinea pig skin
30. Inflammatory, tumor initiating and promoting activities of polycyclic aromatic hydrocarbons and diterpene esters in mouse skin as compared with their prostaglandin releasing potency in vitro
31. Events associated with mouse skin tumor promotion with respect to arachidonic acid metabolism: A comparison between SENCAR and NMRI mice
32. EGF and TPA stimulate de novo synthesis of PGHS-1 and PGHS-2 through different signal transduction pathways
33. Prostaglandin E-mediated mitogenic stimulation of mouse epidermis in vivo by divalent cation ionophore A 23187 and by tumor promoter 12-O-tetradecanoylphorbol-13-acetate
34. Ultraviolet B injury increases prostaglandin synthesis through a tyrosine kinase-dependent pathway. Evidence for UVB-induced epidermal growth factor receptor activation
35. Oxidative stress mediates synthesis of cytosolic phospholipase A2 after UVB injury
36. Regulation of prostaglandin endoperoxide H synthase by glucocorticoids and activators of protein kinase C in the human amnion
37. Chemopreventive activity of Celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis
38. Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis
39. Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: Evidence for growth suppression by inhibiting COX-2 expression
40. Differential effects of various skin tumor-promoting agents on prostaglandin E2 release from primary cultures of mouse epidermal cells
41. Effect of smokeless tobacco extract on human gingival keratinocyte levels of prostaglandin E2 and interleukin-1
42. Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis
43. Effect of cyclic AMP and prostaglandin E2 on the induction of nitric oxide- and prostanoid-forming pathways in cultured rat mesangial cells
44. Prostaglandin E2-protein kinase A signaling and protein phosphatases-1 and -2A regulate human head and neck squamous cell carcinoma motility, adherence, and cytoskeletal organization
45. Molecular aspects of the structures and functions of the prostaglandin E receptors
46. Points of convergence between Ca2+ and Ras signalling pathways
47. Arachidonic acid metabolites in cutaneous carcinomas. Evidence suggesting that elevated levels of prostaglandins in basal cell carcinomas are associated with an aggressive growth pattern
48. Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines
49. Characterization of EP prostanoid receptor subtypes in primary cultures of bovine ciliary epithelial cells by immunofluorescent microscopy and functional studies
50. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
51. Oxidant stress and multistage skin carcinogenesis
52. The concerted regulation of cPLA2, COX2, and lipocortin 1 expression by IL-1 beta in A549 cells
53. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2
54. Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope
55. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor
56. Prostaglandin E(2) (PGE(2)) induces the c-fos and c-jun expressions via the EP(1) subtype of PGE receptor in mouse osteoblastic MC3T3-E1 cells
57. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion
58. Inhibitory effect of a prostaglandin E receptor subtype EP(1) selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice
59. Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis